Agnès Hardouin - Concepedia

Author

Agnès Hardouin

Also Known As

A Hardouin, A. Hardouin, A. L. Tarbé de Saint Hardouin, A.-L. Tarbé de Saint Hardouin, Agnes Hardouin, Agnès Hardouin, Agnès Hardouin, Alain Calender, Caron, Olivier, Dominique Stoppa-Lyonnet

Publications

2.6K

Citations

H-Index

Concepts

All Affiliations

Centre François Baclesse Inserm Institut Curie Université de Rouen Normandie Centre Léon Bérard

About

Agnès Hardouin is an author at Centre François Baclesse specializing in medicine, genetics, and breast cancer.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	13	819
2	Health Sciences	4	4	405
3	Engineering	1	1	95
4	Natural Sciences	1	1	17
5	Nursing	1	1	107

Agnès Hardouin

Publications

1.7K

Citations

H-Index

Page 1

	Year	Citations
Next-generation sequencing for the diagnosis of hereditary breast and ovarian cancer using genomic capture targeting multiple candidate genes Laurent Castéra, Sophie Krieger, Antoine Rousselin, European Journal of Human Genetics Breast OncologyOncologySequencingTumor HeterogeneityMedicine	2014	254
Guidelines for splicing analysis in molecular diagnosis derived from a set of 327 combined in silico/in vitro studies on BRCA1 and BRCA2 variants Claude Houdayer, Virginie Caux‐Moncoutier, Sophie Krieger, Human Mutation	2012	238
Common Breast Cancer Susceptibility Alleles and the Risk of Breast Cancer for <i>BRCA1</i> and <i>BRCA2</i> Mutation Carriers: Implications for Risk Prediction Antonis C. Antoniou, Jonathan Beesley, Lesley McGuffog, Cancer Research	2010	184
Screening <i>BRCA1</i> and <i>BRCA2</i> unclassified variants for splicing mutations using reverse transcription PCR on patient RNA and an ex vivo assay based on a splicing reporter minigene Céline Bonnet, Sophie Krieger, Myriam Vézain, Journal of Medical Genetics	2008	126
Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2 Anna Marie Mulligan, Fergus J. Couch, Daniel Barrowdale, Breast Cancer Research	2011	118
Clinical impact of pharmacokinetically-guided dose adaptation of 5-fluorouracil: results from a multicentric randomized trial in patients with locally advanced head and neck carcinomas. R. Féty, F. Rolland, Muriel Barberi‐Heyob, PubMed MedicineMetronomic TherapyPharmacologyTherapeutic ActivityDose Adaptation	1998	114
One-Year Longitudinal Study of Fatigue, Cognitive Functions, and Quality of Life After Adjuvant Radiotherapy for Breast Cancer Sabine Noal, Christelle Lévy, Agnès Hardouin, International Journal of Radiation OncologyBiologyPhysics NursingQuality Of LifeRadiation TherapyMedicineCancer Management	2010	107
Significant Contribution of Germline <b> <i>BRCA2</i> </b> Rearrangements in Male Breast Cancer Families Isabelle Tournier, Brigitte Bressac–de Paillerets, Hagay Sobol, Cancer Research Breast OncologyEngineeringCancer PathologyGeneticsPathology	2004	95
Contribution of bioinformatics predictions and functional splicing assays to the interpretation of unclassified variants of the BRCA genes Jean Christophe Théry, Sophie Krieger, Pascaline Gaildrat, European Journal of Human Genetics BiologyFunctional GenomicsBioinformatics PredictionsGeneticsComputational Genomics	2011	94
Multiple sequence variants of <i>BRCA2</i> exon 7 alter splicing regulation Pascaline Gaildrat, Sophie Krieger, Daniela Di Giacomo, Journal of Medical Genetics	2012	45

Page 1